Results 171 to 180 of about 1,893,405 (266)
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth +13 more
wiley +1 more source
Value of Endoanal Ultrasound in the Comprehensive Management of Crohn's Disease-Associated Anorectal Fistulas: A Case Report. [PDF]
Abarca Magallon AS +4 more
europepmc +1 more source
Acelerar la acción en la atención primaria de salud. [PDF]
Luciani S +6 more
europepmc +1 more source
Circular Economy: A Pathway to Integrated Value Creation for Business and Society
ABSTRACT Amid growing environmental pressures and the pressing demand to advance sustainable development, the circular economy (CE) has positioned itself as a transformative business approach capable of safeguarding favourable ecosystem conditions through the application of key R‐strategies.
Saudi‐Yulieth Enciso‐Alfaro +1 more
wiley +1 more source
Formalin, ethanol, and RNAlater are commonly used fixatives for morphological and molecular studies, but each has limitations when specimen availability is low, as is often the case with field‐collected non‐model organisms. Here, we evaluate KINFix, a non‐toxic alcohol‐based fixative, in four invertebrate taxa and show that it effectively preserves ...
Irene del Olmo +3 more
wiley +1 more source
Tumoral Melanosis: A Benign Mimicker of Malignant Disease. [PDF]
Gomez-Picos A +4 more
europepmc +1 more source
Mapping Instrument Preferences for Deforestation Policies Based on EU Public Consultation Data
ABSTRACT Policy makers can choose among many alternative policy instruments to reduce the impact of EU commodity imports on forests and related biodiversity loss in the world. Changes in the instrument mix affect a wide range of stakeholder groups with varying strategic interests and corresponding policy preferences.
Daniel Braun, Dennis Abel, Jan Börner
wiley +1 more source
[Epidemiology of childhood leukemia in Mexico and Latin America: Effects of vulnerability and social justice]. [PDF]
Núñez-Enríquez JC +9 more
europepmc +1 more source
Calidad de la canal y de la carne en corderos ligeros de raza segureña [PDF]
Alcalde Aldea, María Jesús +7 more
core
ABSTRACT Introduction In Mexico, the 5‐year overall survival (OS) rate for pediatric acute lymphoblastic leukemia (ALL) ranges from 45% to 85%, markedly lower than the ∼90% reported in high‐income countries, where cytogenomic testing is essential for accurate risk stratification and therapeutic decision‐making.
Rosa María González Arreola +8 more
wiley +1 more source

